Lancet Capital

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$9M
Portfolio companies 2
Lead investments 1
Key employees Soon

Areas of investment

  • Medical
  • Biotechnology

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Avanti Capital England, London, United Kingdom
Daisan Bank Japan, Matsusaka, Mie Prefecture
Emerge Israel, Tel Aviv, Tel Aviv
Gaoxin Kechuang China, Fujian, Xiamen
Guidewire Software California, San Mateo, United States
Nordea Finland, Helsinki, Southern Finland
Qinglin Huacheng Beijing, Beijing, China
Shanghai Yaoji Technology China, Jiading District
Sunovo Capital China, Hangzhou, Zhejiang
Uniqorn Ventures India, Maharashtra, Mumbai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Scion Pharmaceuticals

Biotechnology
Medical
$17M15 Jul 2002 United States, Boston

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Lancet Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: